Clinical Trial Update: Phase III Long-Term Extension Study With Dexpramipexole [Phase 3]

View source ↗

Summary

Areteia Therapeutics reports termination of the Phase III long-term extension study of dexpramipexole for eosinophilic asthma. The trial status indicates the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Asthma

Drugs mentioned

• Dexpramipexole (dexpramipexole)

Snippet

Sponsor: Areteia Therapeutics | Conditions: Eosinophilic Asthma | Phase 3 | Status: TERMINATED